Skip to main content
. 2012 Apr 12;4:167–174. doi: 10.2147/IJWH.S18209

Figure 1.

Figure 1

Mean percent changes from baseline in lumbar spine and total hip bone mineral density in women receiving 5 mg risedronate daily ( Inline graphic), 35 mg slow-release risedronate once weekly 30 minutes after breakfast ( Inline graphic), and 35 mg slow-release risedronate before breakfast ( Inline graphic). Reproduced with permission from McClung et al.35

Abbreviation: SE, standard error of the mean.